JMP-29072-93164 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-11-22
Dose 1 — Moderna
Co-administered: Flu:Hib:Polio:Rotavirus:Tetanus
2022-12-13
Registered in v-safe
2022-12-13
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-12-20
Health check-in — day 28, dose 1, under 3
Feeling: Fair

Under 3 check-in
2022-12-27
Survey response — day 35, dose 1, under 3
MedDRA: Cough, Pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities

Free text: Runny nose. Coughing. Fever. Aches

MedDRA releases: 2024-11 · check-in free text available
2023-01-03
Health check-in — day 42, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-02-21
Health check-in — 3 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-05-25
Health check-in — 6 months, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-11-22	Moderna	Flu:Hib:Polio:Rotavirus:Tetanus

Free text

Release 12 (Under 3) — day 35, dose 1, under 3

2022-12-27

Symptoms: Runny nose. Coughing. Fever. Aches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release